View in EDS

Longitudinal multi-omics study of palbociclib resistance in HR-positive/HER2-negative metastatic breast cancer.

Saved in:
Bibliographic Details
Title: Longitudinal multi-omics study of palbociclib resistance in HR-positive/HER2-negative metastatic breast cancer.
Authors: Park YH; Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. yhparkhmo@skku.edu.; Department of Health Science and Technology, School of Medicine & SAIHST, Sungkyunkwan University, Seoul, Republic of Korea. yhparkhmo@skku.edu., Im SA; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul National University, Seoul, Republic of Korea. moisa@snu.ac.kr., Park K; Samsung Genome Institute, Samsung Medical Center, Seoul, Republic of Korea., Wen J; Oncology Research & Development, Pfizer Inc, San Diego, CA, USA., Lee KH; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul National University, Seoul, Republic of Korea., Choi YL; Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.; Department of Health Science and Technology, School of Medicine & SAIHST, Sungkyunkwan University, Seoul, Republic of Korea., Lee WC; Oncology Research & Development, Pfizer Inc, San Diego, CA, USA., Min A; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul National University, Seoul, Republic of Korea., Bonato V; Biostatistics, Pfizer Inc, San Diego, CA, USA., Park S; Department of Health Science and Technology, School of Medicine & SAIHST, Sungkyunkwan University, Seoul, Republic of Korea., Ram S; Drug Safety R&D, Pfizer Inc, San Diego, CA, USA., Lee DW; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul National University, Seoul, Republic of Korea., Kim JY; Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Lee SK; Research Center for Future Medicine, Samsung Medical Center, Seoul, Republic of Korea., Lee WW; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul National University, Seoul, Republic of Korea., Lee J; Oncology Research & Development, Pfizer Inc, San Diego, CA, USA., Kim M; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul National University, Seoul, Republic of Korea., Kim HS; Pfizer Oncology, Seoul, Republic of Korea., Weinrich SL; Oncology Research & Development, Pfizer Inc, San Diego, CA, USA., Ryu HS; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul National University, Seoul, Republic of Korea., Kim TY; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul National University, Seoul, Republic of Korea., Dann S; Oncology Research & Development, Pfizer Inc, San Diego, CA, USA., Kim YJ; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul National University, Seoul, Republic of Korea., Fernandez DR; Oncology Research & Development, Pfizer Inc, San Diego, CA, USA., Koh J; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul National University, Seoul, Republic of Korea., Wang S; Oncology Research & Development, Pfizer Inc, San Diego, CA, USA., Park SY; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul National University, Seoul, Republic of Korea., Deng S; Biostatistics, Pfizer Inc, San Diego, CA, USA., Powell E; Oncology Research & Development, Pfizer Inc, San Diego, CA, USA., Ravi RK; Oncology Research & Development, Pfizer Inc, San Diego, CA, USA., Bienkowska J; Oncology Research & Development, Pfizer Inc, San Diego, CA, USA., Rejto PA; Oncology Research & Development, Pfizer Inc, San Diego, CA, USA., Park WY; Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.; Department of Health Science and Technology, School of Medicine & SAIHST, Sungkyunkwan University, Seoul, Republic of Korea.; Samsung Genome Institute, Samsung Medical Center, Seoul, Republic of Korea., Kan Z; Oncology Research & Development, Pfizer Inc, San Diego, CA, USA. zhengyan.kan@pfizer.com.
Source: Genome medicine [Genome Med] 2023 Jul 20; Vol. 15 (1), pp. 55. Date of Electronic Publication: 2023 Jul 20.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101475844 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-994X (Electronic) Linking ISSN: 1756994X NLM ISO Abbreviation: Genome Med Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37475004
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Longitudinal multi-omics study of palbociclib resistance in HR-positive/HER2-negative metastatic breast cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Park+YH%22">Park YH</searchLink>; Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. yhparkhmo@skku.edu.; Department of Health Science and Technology, School of Medicine & SAIHST, Sungkyunkwan University, Seoul, Republic of Korea. yhparkhmo@skku.edu.<br /><searchLink fieldCode="AU" term="%22Im+SA%22">Im SA</searchLink>; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul National University, Seoul, Republic of Korea. moisa@snu.ac.kr.<br /><searchLink fieldCode="AU" term="%22Park+K%22">Park K</searchLink>; Samsung Genome Institute, Samsung Medical Center, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Wen+J%22">Wen J</searchLink>; Oncology Research & Development, Pfizer Inc, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Lee+KH%22">Lee KH</searchLink>; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul National University, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Choi+YL%22">Choi YL</searchLink>; Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.; Department of Health Science and Technology, School of Medicine & SAIHST, Sungkyunkwan University, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+WC%22">Lee WC</searchLink>; Oncology Research & Development, Pfizer Inc, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Min+A%22">Min A</searchLink>; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul National University, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Bonato+V%22">Bonato V</searchLink>; Biostatistics, Pfizer Inc, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Park+S%22">Park S</searchLink>; Department of Health Science and Technology, School of Medicine & SAIHST, Sungkyunkwan University, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Ram+S%22">Ram S</searchLink>; Drug Safety R&D, Pfizer Inc, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Lee+DW%22">Lee DW</searchLink>; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul National University, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+JY%22">Kim JY</searchLink>; Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+SK%22">Lee SK</searchLink>; Research Center for Future Medicine, Samsung Medical Center, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+WW%22">Lee WW</searchLink>; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul National University, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+J%22">Lee J</searchLink>; Oncology Research & Development, Pfizer Inc, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Kim+M%22">Kim M</searchLink>; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul National University, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+HS%22">Kim HS</searchLink>; Pfizer Oncology, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Weinrich+SL%22">Weinrich SL</searchLink>; Oncology Research & Development, Pfizer Inc, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Ryu+HS%22">Ryu HS</searchLink>; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul National University, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+TY%22">Kim TY</searchLink>; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul National University, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Dann+S%22">Dann S</searchLink>; Oncology Research & Development, Pfizer Inc, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Kim+YJ%22">Kim YJ</searchLink>; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul National University, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Fernandez+DR%22">Fernandez DR</searchLink>; Oncology Research & Development, Pfizer Inc, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Koh+J%22">Koh J</searchLink>; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul National University, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Wang+S%22">Wang S</searchLink>; Oncology Research & Development, Pfizer Inc, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Park+SY%22">Park SY</searchLink>; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul National University, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Deng+S%22">Deng S</searchLink>; Biostatistics, Pfizer Inc, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Powell+E%22">Powell E</searchLink>; Oncology Research & Development, Pfizer Inc, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Ravi+RK%22">Ravi RK</searchLink>; Oncology Research & Development, Pfizer Inc, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Bienkowska+J%22">Bienkowska J</searchLink>; Oncology Research & Development, Pfizer Inc, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Rejto+PA%22">Rejto PA</searchLink>; Oncology Research & Development, Pfizer Inc, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Park+WY%22">Park WY</searchLink>; Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.; Department of Health Science and Technology, School of Medicine & SAIHST, Sungkyunkwan University, Seoul, Republic of Korea.; Samsung Genome Institute, Samsung Medical Center, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kan+Z%22">Kan Z</searchLink>; Oncology Research & Development, Pfizer Inc, San Diego, CA, USA. zhengyan.kan@pfizer.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101475844%22">Genome medicine</searchLink> [Genome Med] 2023 Jul 20; Vol. 15 (1), pp. 55. <i>Date of Electronic Publication: </i>2023 Jul 20.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101475844 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1756-994X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221756994X%22">1756994X </searchLink><i>NLM ISO Abbreviation: </i>Genome Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37475004
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s13073-023-01201-7
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 55
    Titles:
      – TitleFull: Longitudinal multi-omics study of palbociclib resistance in HR-positive/HER2-negative metastatic breast cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Park YH
      – PersonEntity:
          Name:
            NameFull: Im SA
      – PersonEntity:
          Name:
            NameFull: Park K
      – PersonEntity:
          Name:
            NameFull: Wen J
      – PersonEntity:
          Name:
            NameFull: Lee KH
      – PersonEntity:
          Name:
            NameFull: Choi YL
      – PersonEntity:
          Name:
            NameFull: Lee WC
      – PersonEntity:
          Name:
            NameFull: Min A
      – PersonEntity:
          Name:
            NameFull: Bonato V
      – PersonEntity:
          Name:
            NameFull: Park S
      – PersonEntity:
          Name:
            NameFull: Ram S
      – PersonEntity:
          Name:
            NameFull: Lee DW
      – PersonEntity:
          Name:
            NameFull: Kim JY
      – PersonEntity:
          Name:
            NameFull: Lee SK
      – PersonEntity:
          Name:
            NameFull: Lee WW
      – PersonEntity:
          Name:
            NameFull: Lee J
      – PersonEntity:
          Name:
            NameFull: Kim M
      – PersonEntity:
          Name:
            NameFull: Kim HS
      – PersonEntity:
          Name:
            NameFull: Weinrich SL
      – PersonEntity:
          Name:
            NameFull: Ryu HS
      – PersonEntity:
          Name:
            NameFull: Kim TY
      – PersonEntity:
          Name:
            NameFull: Dann S
      – PersonEntity:
          Name:
            NameFull: Kim YJ
      – PersonEntity:
          Name:
            NameFull: Fernandez DR
      – PersonEntity:
          Name:
            NameFull: Koh J
      – PersonEntity:
          Name:
            NameFull: Wang S
      – PersonEntity:
          Name:
            NameFull: Park SY
      – PersonEntity:
          Name:
            NameFull: Deng S
      – PersonEntity:
          Name:
            NameFull: Powell E
      – PersonEntity:
          Name:
            NameFull: Ravi RK
      – PersonEntity:
          Name:
            NameFull: Bienkowska J
      – PersonEntity:
          Name:
            NameFull: Rejto PA
      – PersonEntity:
          Name:
            NameFull: Park WY
      – PersonEntity:
          Name:
            NameFull: Kan Z
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 20
              M: 07
              Text: 2023 Jul 20
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1756-994X
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Genome medicine
              Type: main
ResultId 1